Video

Spotting the Signs of Uterine Cancer

Author(s):

Dennis R. Scribner, M.D.

While there is no test, such as a mamogram or colonoscopy, for uterine cancer, vaginal bleeding is a telltale sign of the disease.

Dennis R. Scribner, M.D., FACOG, FACS, clinical associate professor for the University of Arizona School of Medicine, Arizona Oncology, explains an important telltale sign of uterine cancer.

While there is no test for uterine cancer (such as a mammogram for breast cancer or a colonoscopy for colorectal cancer) vaginal bleeding is one of the first signs that a woman might have uterine cancer. so, Scribner suggests that women who are experiencing abnormal bleeding contact their health care providers.

Related Videos
Image of woman.
Image of woman.
Image of woman.
Image of man wearing baseball cap backwards.
Image of smiling doctor.
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
Image od grey haired Doctor.
Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.
Dr. Emre Yekedüz highlighted strategies that may improve patients' quality of life and mitigate treatment-related side effects in renal cell carcinoma.
Related Content
Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer
March 6th 2025

Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer

Ryan Scott
Artificial intelligence aids in polyp detection, enhancing colonoscopy effectiveness and reducing the risk of colorectal cancer progression in patients.
‘I’m Not Always Happy, But I’m Happy Right Now’ with Endometrial Cancer
April 15th 2021

‘I’m Not Always Happy, But I’m Happy Right Now’ with Endometrial Cancer

Jamie Cesanek
In this episode of the “CURE® Talks Cancer” podcast, Pamela Hegg details her journey with a rare form of endometrial cancer and explains how she’s able to stay positive through multiple recurrences.
Image of doctor with brown hair.
February 25th 2025

Some KRAS Mutations Associated With Worse Outcomes in Pancreatic Cancer

Dr. Vaia Florou
In patients with pancreatic ductal adenocarcinoma, KRAS G12D and G12V mutations hare associated with worse patient outcomes, researchers have found.
Site Logo
September 13th 2018

A Survivor and Her Running Shoes

Brielle Benyon
“I’m just a single person. I don’t have money. I don’t have political influence. What I do have is my running shoes,” she said during the interview.
Dr. Robert Jones is a professor of Clinical Cancer Research at The University of Glasgow School of Cancer Sciences, in Scotland.
February 15th 2025

Bavencio Has Efficacy in The Real-World Treatment of Urothelial Cancer

Dr. Robert Jones
Following treatment with Bavencio, patients with urothelial cancer lived for 17 months and their cancer remained stable for nine months.
Image of man with black hair.
February 3rd 2025

Rybrevant Alone and in Combo With Chemo is Efficacious in Wildtype+ mCRC

Ryan Scott
Dr. Filippo Pietrantonio discusses OrigAMI-1 trial data which assessed Rybrevant in mutated, wild-type, non-HER2-amplified metastatic colorectal cancer.